{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:02:41Z","timestamp":1791946961142,"version":"4.3.4"},"reference-count":25,"publisher":"BMJ","issue":"2","funder":[{"name":"R&D UNICANCER"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,12,3]]},"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The currently ongoing Epidemiological Strategy and Medical Economics (ESME) research programme aims at centralising real-life data on oncology care for epidemiological research purposes. We draw on results from the metastatic breast cancer (MBC) cohort to illustrate the methodology used for data collection in the ESME research programme.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>All consecutive \u226518 years patients with MBC treatment initiated between 2008 and 2014 in one of the 18 French Comprehensive Cancer Centres were selected. Diagnostic, therapeutic and follow-up data (demographics, primary tumour, metastatic disease, treatment patterns and vital status) were collected through the course of the disease. Data collection is updated annually.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Finding to date<\/jats:title>\n                    <jats:p>With a recruitment target of 30 000 patients with MBC by 2019, we currently screened a total of 45\u2009329 patients, and &gt;16\u2009700 patients with a metastatic disease treatment initiated after 2008 have been selected. 20.7% of patients had an hormone receptor (HR)-negative MBC, 73.7% had a HER2-negative MBC and 13.9% were classified as triple-negative BC (ie, HER2 and HR status both negative). Median follow-up duration from MBC diagnosis was 48.55 months for the whole cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Future plans<\/jats:title>\n                    <jats:p>These real-world data will help standardise the management of MBC and improve patient care. A dozen of ancillary research projects have been conducted and some of them are already accepted for publication or ready to be issued. The ESME research programme is expanding to ovarian cancer and advanced\/metastatic lung cancer. Our ultimate goal is to achieve a continuous link to the data of the cohort to the French national Health Data System for centralising data on healthcare reimbursement (drugs, medical procedures), inpatient\/outpatient stays and visits in primary\/secondary care settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT03275311\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\">NCT03275311<\/jats:ext-link>\n                      ; Pre-results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-023568","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T06:29:59Z","timestamp":1550816999000},"page":"e023568","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":57,"title":["The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct03275311","registry":"10.18810\/clinical-trials-gov","type":"preResults"},{"clinical-trial-number":"nct03275311","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"David","family":"P\u00e9rol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Robain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Arveux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Mathoulin-P\u00e9lissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Chamorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Asselain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Berchery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gourgou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Breton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Delaine-Clisant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Mons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Di\u00e9ras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Carton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Val\u00e9rie","family":"Guizard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Laborde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Ange","family":"Mouret-Reynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Perrocheau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Campion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Velten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Cailliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Ezzalfani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtane","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"2024051713553089000_9.2.e023568.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.7487"},{"key":"2024051713553089000_9.2.e023568.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00600.x"},{"key":"2024051713553089000_9.2.e023568.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.2352"},{"key":"2024051713553089000_9.2.e023568.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.9650"},{"key":"2024051713553089000_9.2.e023568.5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jamainternmed.2015.2829","article-title":"The strength of association between surrogate end points and survival in oncology: a systematic review of trial-level meta-analyses","volume":"175","author":"Prasad","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2024051713553089000_9.2.e023568.6","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.2017.72.6414","article-title":"Untapped potential of observational research to inform clinical decision making: American society of clinical oncology research statement","volume":"35","author":"Visvanathan","year":"2017","journal-title":"J Clin Oncol"},{"key":"2024051713553089000_9.2.e023568.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.12.010"},{"key":"2024051713553089000_9.2.e023568.8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinepi.2015.10.014","article-title":"Standards and guidelines for observational studies: quality is in the eye of the beholder","volume":"71","author":"Morton","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2024051713553089000_9.2.e023568.9","doi-asserted-by":"publisher","DOI":"10.2307\/2683903"},{"key":"2024051713553089000_9.2.e023568.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.3.278"},{"key":"2024051713553089000_9.2.e023568.11","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B"},{"key":"2024051713553089000_9.2.e023568.12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.19.1.17"},{"key":"2024051713553089000_9.2.e023568.13","unstructured":"Institut National du Cancer (INCa). Information sur le cancer. http:\/\/www.e-cancer.fr\/ (Accessed 04 Jul 2017)."},{"key":"2024051713553089000_9.2.e023568.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66544-0"},{"key":"2024051713553089000_9.2.e023568.15","unstructured":"Binder-Foucard F , Belot A , Delafosse P , et al . Estimation nationale de l\u2019incidence et de la mortalit\u00e9 par cancer en France entre 1980 et 2012. Partie 1 \u2013 Tumeurs solides. Saint-Maurice (Fra): Institut de veille sanitaire, 2013."},{"key":"2024051713553089000_9.2.e023568.16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw260"},{"key":"2024051713553089000_9.2.e023568.17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2018.03.015","article-title":"Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort","volume":"96","author":"Gobbini","year":"2018","journal-title":"Eur J Cancer"},{"key":"2024051713553089000_9.2.e023568.18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejca.2018.03.013","article-title":"Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients","volume":"95","author":"Jacquet","year":"2018","journal-title":"Eur J Cancer"},{"key":"2024051713553089000_9.2.e023568.19","unstructured":"Association des Epid\u00e9miologistes de Langue Fran\u00e7aise (ADELF). D\u00e9ontologie et bonnes pratiques en \u00e9pid\u00e9miologie, recommendations r\u00e9vis\u00e9es. 2007."},{"key":"2024051713553089000_9.2.e023568.20","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1471"},{"key":"2024051713553089000_9.2.e023568.21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn424"},{"key":"2024051713553089000_9.2.e023568.22","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/48\/12\/101"},{"key":"2024051713553089000_9.2.e023568.23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp369"},{"key":"2024051713553089000_9.2.e023568.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6745"},{"key":"2024051713553089000_9.2.e023568.25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.therap.2017.12.008","article-title":"Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases","volume":"73","author":"Berda\u00ef","year":"2018","journal-title":"Therapie"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-023568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:56:05Z","timestamp":1715975765000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-023568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,21]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/bmjopen-2018-023568"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-023568","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}